Skip to main content

Bids To Halt Upcoming Ohio’s Opioid Trial Rejected

Bids To Halt Upcoming Ohio’s Opioid Trial Rejected

Bids To Halt Upcoming Ohio’s Opioid Trial Rejected

Introduction

On Thursday, the Sixth Circuit rejected the efforts by the Ohio attorney general and drug companies to impede an upcoming opioid trial accusing drugmakers of fueling the opioid crisis.

The panel, along with rejecting the state’s arguments that the counties involved usurped its parent of the nation authority, also rejected the drugmakers' bid to disqualify the judge overseeing the trial.

Attorney General Dave Yost argued through an August 30 petition that the lawsuits filed by the counties threatened the state’s authority to protect the public welfare. The panel ruled, stating that the state hadn’t met, the high bar required for obtaining a writ of mandamus, also Yost did not show how the state would have been harmed by the lawsuits brought by Summit County and Cuyahoga County.

Ohio’s governor, Mike DeWine, had opposed the attorney general’s bid stating that he would refuse any legislation that gives the attorney general control over the counties’ suit as the local governments have shown a significant impact of the opioid epidemic.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!